Reversal of acute myelogenous leukemia in humanized SCID mice using a novel adoptive transfer approach.

Cesano, A; Visonneau, S; Cioé, L; Clark, S C; Rovera, G; Santoli, D

Cesano, A; Visonneau, S; Cioé, L; Clark, S C; Rovera, G; Santoli, D.

Affiliation

Cesano A; Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania 19104.

J Clin Invest ; 94(3): 1076-84, 1994 Sep.

Article in En | MEDLINE | ID: mdl-8083348

Subject(s)

Immunotherapy, Adoptive; Killer Cells, Lymphokine-Activated; Leukemia, Myeloid, Acute/therapy; Lymphocyte Transfusion; Animals; Cell Line; Clone Cells; Cytotoxicity, Immunologic; Etoposide/therapeutic use; Gamma Rays; Humans; Immunosuppression Therapy; Killer Cells, Natural/immunology; Killer Cells, Natural/radiation effects; Mice; Mice, SCID; Polymerase Chain Reaction; Transplantation, Heterologous; Tumor Cells, Cultured

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Killer Cells, Lymphokine-Activated / Immunotherapy, Adoptive / Lymphocyte Transfusion Limits: Animals / Humans Language: En Journal: J Clin Invest Year: 1994 Type: Article

Fulltext

XML

PubMed Links

Search on Google